Thompson Siegel & Walmsley LLC lessened its position in MetLife, Inc. (NYSE:MET – Free Report) by 0.9% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 168,634 shares of the financial services provider’s stock after selling 1,500 shares during the quarter. Thompson Siegel & Walmsley LLC’s holdings in MetLife were worth $9,533,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds have also recently bought and sold shares of the company. Synovus Financial Corp increased its position in MetLife by 11.4% in the 1st quarter. Synovus Financial Corp now owns 17,847 shares of the financial services provider’s stock worth $1,260,000 after buying an additional 1,829 shares during the period. Brighton Jones LLC bought a new position in MetLife in the 1st quarter worth approximately $225,000. Baird Financial Group Inc. grew its holdings in shares of MetLife by 179.7% during the 1st quarter. Baird Financial Group Inc. now owns 540,081 shares of the financial services provider’s stock worth $37,957,000 after purchasing an additional 346,999 shares in the last quarter. Zions Bancorporation N.A. grew its holdings in shares of MetLife by 937.3% during the 1st quarter. Zions Bancorporation N.A. now owns 5,861 shares of the financial services provider’s stock worth $412,000 after purchasing an additional 5,296 shares in the last quarter. Finally, Brown Brothers Harriman & Co. grew its holdings in shares of MetLife by 114.5% during the 1st quarter. Brown Brothers Harriman & Co. now owns 3,419 shares of the financial services provider’s stock worth $240,000 after purchasing an additional 1,825 shares in the last quarter. Institutional investors and hedge funds own 88.14% of the company’s stock.
Analyst Upgrades and Downgrades
Several analysts have recently weighed in on MET shares. Jefferies Financial Group raised MetLife from a “hold” rating to a “buy” rating and lifted their price objective for the stock from $58.00 to $72.00 in a report on Wednesday, September 13th. Morgan Stanley lifted their price objective on MetLife from $79.00 to $80.00 and gave the stock an “overweight” rating in a report on Thursday, November 2nd. JPMorgan Chase & Co. decreased their price objective on MetLife from $85.00 to $82.00 and set an “overweight” rating on the stock in a report on Friday, October 6th. Barclays reaffirmed an “overweight” rating and issued a $71.00 price target on shares of MetLife in a research note on Friday. Finally, Argus boosted their price target on MetLife from $70.00 to $77.00 and gave the company a “buy” rating in a research note on Monday, August 14th. Three research analysts have rated the stock with a hold rating and nine have issued a buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $75.45.
MetLife Trading Up 0.8 %
Shares of MET stock traded up $0.52 on Friday, reaching $62.55. 4,120,861 shares of the stock were exchanged, compared to its average volume of 4,049,476. The stock has a market cap of $46.30 billion, a PE ratio of 23.00, a P/E/G ratio of 0.67 and a beta of 1.06. MetLife, Inc. has a one year low of $48.95 and a one year high of $77.36. The company has a debt-to-equity ratio of 0.62, a current ratio of 0.13 and a quick ratio of 0.13. The stock has a 50 day moving average price of $61.99 and a 200 day moving average price of $59.20.
MetLife (NYSE:MET – Get Free Report) last released its earnings results on Wednesday, November 1st. The financial services provider reported $1.97 earnings per share for the quarter, missing analysts’ consensus estimates of $1.99 by ($0.02). The firm had revenue of $15.87 billion for the quarter, compared to the consensus estimate of $17.49 billion. MetLife had a return on equity of 19.14% and a net margin of 3.60%. The company’s revenue was down 28.8% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.21 EPS. Equities research analysts forecast that MetLife, Inc. will post 7.55 EPS for the current fiscal year.
MetLife Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Thursday, December 14th. Investors of record on Thursday, November 9th will be issued a $0.52 dividend. The ex-dividend date is Wednesday, November 8th. This represents a $2.08 dividend on an annualized basis and a yield of 3.33%. MetLife’s dividend payout ratio is presently 76.47%.
MetLife Company Profile
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
- Five stocks we like better than MetLife
- Election Stocks: How Elections Affect the Stock Market
- MarketBeat Week in Review – 11/13 – 11/17
- How to Invest in the Entertainment Industry
- 3 large caps with red hot RSIs with upside
- Investing in Agriculture 101: How to Invest in Agriculture
- Johnson Controls International: Nothing but upside for investors
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.